The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer Female · Breast Cancer · Breast Cancer Metastatic · Estrogen Receptor-positive Breast Cancer · HER2-positive Breast Cancer · Stage IV Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Nancy Lin, MD) · nancy_lin@dfci.harvard.edu · 617-632-2335
Contact: Principal Investigator (Nancy Lin, MD)

Study leads

Nancy Lin, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

Metastatic Breast Cancer · HER2 Low Breast Carcinoma · HER2-negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Biliary Tract Cancer · Breast Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Denver, United States · Miami, United States

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Invasive Ductal Breast Carcinoma · Invasive Ductal Carcinoma, Breast · DCIS

Abroad (travel likely)RecruitingPHASE2

Norwalk, United States · Miami, United States